Medical Device Manufacturer · Post-acquisition · First 100 days and continuing oversight
The owner had the keys to the medical device manufacturer. The assumptions now had to work in real life.
Published · Reviewed by The Diligence Standard Team · Updated
The owner of the medical device manufacturer finally controlled the records and could compare the promises made before closing with daily reality. The first sign of a gap was that customer concentration.
What was at stake
The purchase was already complete. For the owner, delay could allow convert transaction assumptions into measurable execution to become a larger cash, customer or operating problem.
How the evidence changed the decision
The owner needed the story and the records to agree. The review connected IP/design records, equipment/validation and product registrations/quality records, then traced the exceptions back to the operating claim instead of relying on another summary or screenshot.
The important moment was not a dramatic accusation. It was the point at which the records supported “Operating baseline, accountable owner and first-100-day test” more clearly than “Acquisition plan assumed continuity in clean quality system.” The owner could finally see what had changed and why it mattered.
Decision
The owner could assign the issue, set a deadline and monitor the result. The unfinished diligence point became an operating action rather than a report left in a folder.
Evidence reviewed
- IP/design records
- Equipment/validation
- Product registrations/quality records
- Complaint/CAPA history
Post-acquisition review and advisory work provide nonbinding analysis and execution support. They do not guarantee performance or replace legal, tax, audit or regulated professional services.